2025“善城”消化论坛暨枣庄市医学会消化病学年会举行
Qi Lu Wan Bao·2025-12-16 05:52

Core Viewpoint - The conference aims to enhance the diagnosis and treatment of gastrointestinal diseases in the region, aligning with the "Healthy China" strategy and focusing on gastric cancer prevention [1][3] Group 1: Conference Overview - The conference, hosted by the Tengzhou Central People's Hospital, included the "2025 Good City" Gastroenterology Forum and the Zaozhuang Medical Association Gastroenterology Annual Meeting [1] - Key figures such as Zhu Guangyao, the hospital's party secretary, and Li Shuhui, chairman of the Zaozhuang Medical Association Gastroenterology Committee, participated in the event [1][3] Group 2: Expert Contributions - Professor Wang Yongjun from Capital Medical University shared insights on the development trends and clinical practices in gastroenterology, emphasizing the importance of standardized treatment [3] - Renowned experts from various institutions discussed four core topics, providing in-depth academic exchanges [3][5] Group 3: Key Topics Discussed - In the field of endoscopic treatment for biliary and pancreatic diseases, experts detailed ERCP standardized operation techniques and advancements in biliary and pancreatic endoscopy [5] - The focus on early diagnosis and treatment of gastrointestinal tumors included discussions on endoscopic diagnosis and strategies for colorectal cancer screening [5][6] - The importance of multidisciplinary collaboration (MDT) in treating severe cases of acute pancreatitis was highlighted, along with personalized treatment plans based on the latest clinical guidelines [5][6] - The significance of standardized detection methods and eradication treatment for Helicobacter pylori in gastric cancer prevention was thoroughly analyzed [6] Group 4: Conference Impact - The conference served as a platform for efficient academic exchange and skill enhancement in the field of gastroenterology for Tengzhou and surrounding areas [6] - Participants gained insights into the latest diagnostic pathways for key gastrointestinal diseases, which will guide future clinical work and improve treatment quality [6]